InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: xodcode post# 97567

Saturday, 03/25/2017 9:55:10 AM

Saturday, March 25, 2017 9:55:10 AM

Post# of 459475
Yes. I own it. It is not exactly a good comparison with AVXL 2-73 because PLSE is a medical device company. It is easier to gain approval for a medical device versus a drug. Initially, dermatologist will demand PLSE's device for melanoma treatment. However, in the process of testing this device, it was discovered that cancer cells elsewhere in the body were attacked and destroyed by the body's immune system. My simple lay way of explaining this is that normally our immune systems cannot recognize cancer cells. Something is needed to initiate the immune response. Missling sometimes makes references or comparisons to immunotherapy by its drug candidates initiating a response in the body that allows the body to heal itself -- acting on sigma receptors, etc. -- is the way I understand what Missling is saying. It could be that I am simply ignorant and am making the right investment decisions (hopefully) for the wrong reasons, but this is how I am looking at it. Anavex, in my opinion, is a good speculation, but it is longer term than PLSE.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News